1. BRAFp.V600E, p.V600K, and p.V600R Mutations in Malignant Melanoma: Do They Also Differ in Immunohistochemical Assessment and Clinical Features?. Issue 1 (January 2016) Authors: Ponti, Giovanni; Tomasi, Aldo; Maiorana, Antonio; Ruini, Cristel; Maccaferri, Monia; Cesinaro, Anna M.; Depenni, Roberta; Manni, Paola; Gelsomino, Fabio; Giusti, Francesca; Garagnani, Lorella; Pellacani, Giovanni Journal: Applied immunohistochemistry & molecular morphology Issue: Volume 24:Issue 1(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Cemiplimab- and nivolumab-induced myasthenia gravis: two clinical cases. Issue 6 (December 2021) Authors: Canino, Fabio; Pugliese, Giuseppe; Baldessari, Cinzia; Greco, Stefano; Depenni, Roberta; Dominici, Massimo Journal: Tumori Issue: Volume 107:Issue 6(2021) Page Start: NP123 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Clinical outcomes and prognostic factors in recurrent and/or metastatic head and neck cancer patients treated with chemotherapy plus cetuximab as first-line therapy in a real-world setting. (July 2019) Authors: Depenni, Roberta; Cossu Rocca, Maria; Ferrari, Daris; Azzarello, Giuseppe; Baldessari, Cinzia; Alù, Massimiliano; Nolé, Franco; Codecà, Carla; Boscolo, Giorgia; Piccininni, Marco; Cavalieri, Stefano; Bossi, Paolo Journal: European journal of cancer Issue: Volume 115(2019) Page Start: 4 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Corrigendum to "Real world data of cemiplimab in locally advanced and metastatic cutaneous squamous cell carcinoma" [Eur J Canc 157 (2021) 250–258]. (May 2022) Authors: Baggi, Alice; Quaglino, Pietro; Rubatto, Marco; Depenni, Roberta; Guida, Michele; Ascierto, Paolo Antonio; Trojaniello, Claudia; Queirolo, Paola; Saponara, Maristella; Peris, Ketty; Spagnolo, Francesco; Bianchi, Luca; De Galitiis, Federica; Potenza, Maria Concetta; Proietti, Ilaria; Marconcini, R... Journal: European journal of cancer Issue: Volume 166(2022) Page Start: 309 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Corrigendum to "The vicious circle of treatment-induced toxicities in locally advanced head and neck cancer and the impact on treatment intensity" [Crit. Rev. Oncol./Hematol. 116 (2017) 82–88]. (November 2017) Authors: Bossi, Paolo; Cossu Rocca, Maria; Corvò, Renzo; Depenni, Roberta; Guardamagna, Vittorio; Marinangeli, Franco; Miccichè, Francesco; Trippa, Fabio Journal: Critical reviews in oncology/hematology Issue: Volume 119(2017) Page Start: 29 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Dabrafenib–trametinib combination in 'field-practice': an Italian experience. (7th August 2018) Authors: Depenni, Roberta; De Rosa, Francesco; Greco, Stefano; Ridolfi, Laura; Pellacani, Giovanni; Ponti, Giovanni; Cascinu, Stefano; Guidoboni, Massimo Journal: Future oncology Issue: Volume 14:Number 20(2018) Page Start: 2045 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Myocarditis and diaphragmatic rhabdomyolysis with respiratory failure in a patient with metastatic melanoma treated with Nivolumab. (April 2022) Authors: Baldessari, Cinzia; Pugliese, Giuseppe; Venturelli, Marta; Greco, Stefano; Ferrara, Leonardo; Longo, Giuseppe; Dominici, Massimo; Depenni, Roberta Journal: Journal of oncology pharmacy practice Issue: Volume 28:Number 3(2022) Page Start: 750 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Osteonecrosis of the Jaw in a Breast Cancer Patient Treated with Everolimus and a Single Dose of Zoledronic Acid. Issue 5 (22nd March 2017) Authors: Omarini, Claudia; Filieri, Maria E.; Depenni, Roberta; Grizzi, Giulia; Cascinu, Stefano; Piacentini, Federico Journal: Breast journal Issue: Volume 23:Issue 5(2017:Sep./Oct.) Page Start: 610 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Real world data of cemiplimab in locally advanced and metastatic cutaneous squamous cell carcinoma. (November 2021) Authors: Baggi, Alice; Quaglino, Pietro; Rubatto, Marco; Depenni, Roberta; Guida, Michele; Ascierto, Paolo Antonio; Trojaniello, Claudia; Queirolo, Paola; Saponara, Maristella; Peris, Ketty; Spagnolo, Francesco; Bianchi, Luca; De Galitiis, Federica; Potenza, Maria Concetta; Proietti, Ilaria; Marconcini, R... Journal: European journal of cancer Issue: Volume 157(2021) Page Start: 250 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Redistribution of CD8+ T cell subsets in metastatic renal cell carcinoma patients treated with anti‐PD‐1 therapy. Issue 7 (4th May 2022) Authors: De Biasi, Sara; Guida, Annalisa; Lo Tartaro, Domenico; Fanelli, Martina; Depenni, Roberta; Dominici, Massimo; Finak, Greg; Porta, Camillo; Paolini, Annamaria; Borella, Rebecca; Bertoldi, Carlo; Cossarizza, Andrea; Sabbatini, Roberto; Gibellini, Lara Journal: Cytometry Issue: Volume 101:Issue 7(2022) Page Start: 597 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗